The Cancer Community Awards 2022

Nominations Are Now Closed

January 10, 2022

Nominations Open

• • •

February 4, 2022

Nominations Close

• • •

Nominations Review
In Progress

• • •

Late Summer 2022

Finalists Announced

• • •

October 2022

Winners Announced &
Virtual Awards Ceremony

The Cancer Community Awards logo

Redefining cancer care takes a community. From caregivers, healthcare professionals, advocacy groups, scientists, policymakers, and so many others. The Cancer Community Awards (or C2 Awards) celebrate the unsung heroes of cancer care who have dedicated their lives to bringing new hope to people with cancer and their loved ones.

For example, consider nominating a caregiver who supports people with cancer in times of extraordinary need. A difference maker fighting to overcome longstanding disparities among medically underserved communities. An advocacy organization that educates and empowers those along their cancer journey. As well as health professionals and researchers working to bring the latest in early detection, precision medicine, and care to those most in need.

Our awards recognize individuals and organizations across five unique categories. Nominees should have a compelling story about how their work is positively impacting cancer care. Winners in each of the five award categories will receive $50,000 to give to a non-profit serving the cancer community. Nominees must be based in the United States.

2022 Award Categories

Click here to see the Rules and Regulations.

Scientific advancements in cancer care and treatment can save lives, but often ensuring these advancements reach the community-level or more rural areas can be a challenge. Nominees for the C2 Catalyst for Change Award are working to change that.

Nominees for this award drive change at the community-, neighborhood- or hospital-level that results in better cancer care for more people. Maybe a Nominee found a way to get more people screened for cancer at an earlier stage or figured out a creative approach to access new treatments or facilities. Or perhaps the Nominee created a science-based communication, initiative or event that improved access to cancer care and treatment. The C2 Catalyst for Change Award celebrates those who significantly improve access to cancer care for underserved populations.

Award Criteria

  • A Nominee needs to significantly improve the ability of underserved populations to receive high-quality cancer care. Examples include:
    • Improving access to treatment and quality cancer care for patients who previously went without it.
    • Creating more space at a facility that lacked it, facilitating the treatment of more patients.
    • Developing an educational cancer-prevention program in a region with a lack of knowledge.
    • Improving a community’s ability to serve cancer patients through advocacy, government relations or media attention.
  • A Nominee should be able to demonstrate measurable impact, whether as people reached, populations served, procedures increased, screens undertaken, etcetera.
  • Ideally, a Nominee’s process/methodology/approach could be applied in other communities to further expand access to patients in underserved areas.

How a person feels during treatment and what happens outside the clinic can matter just as much as the treatment itself. Nominees for the C2 Catalyst for Care Award work to improve the experience for those with cancer.

Nominees may have developed a system where providers go to patients, helped to make hospitals feel like home, or created a transportation service to provide free rides to medical appointments. A nominee might help manage challenges beyond medical care, such as finances or quality-of-life issues. This award is all about making the experience as easy as possible during an extraordinarily difficult time.

Award Criteria

  • A Nominee needs to significantly enhance the experience of cancer care for individuals at some stage in their cancer treatment, from diagnosis and beyond. Examples include:
    • Developing improved hospital facilities or quality-of-care programs, such as new wards, new food menus or transportation services.
    • Advocating for improved quality-of-life services.
    • Creating easy-to-use digital adherence tools.
    • Improving the experience of families touched by cancer, helping them navigate a very difficult time.
  • A winner should be able to demonstrate measurable impact, whether as people reached, programs started, meals prepared, rides given, etcetera.
  • Ideally, the tools or techniques required to implement the winner’s activity or program should be something that could apply to cancer-care across the country.

Nominees for this new award have worked to overcome longstanding racial and ethnic disparities in cancer care so that all people have equitable access to quality cancer care, including preventive screens and the latest treatments.

Nominees for the C2 Catalyst for Equity Award break down barriers to care, ensuring historically underserved, and underrepresented, populations have access to life-saving cancer screenings and treatments.

Perhaps a Nominee worked with community leaders or organizations to address racial bias in healthcare, launched patient-education programs to elevate the voice of people from diverse backgrounds, improved health literacy in a specific population, or supported the growth and development of healthcare professionals of tomorrow. The C2 Catalyst for Equity Award celebrates those who significantly create greater equity in cancer care.

Award Criteria

  • A Nominee needs to significantly address cancer disparities for historically underserved groups who often experience poorer outcomes, including later diagnosis and higher incidence of mortality. According to the National Cancer Institute, these communities may include Black people, Hispanics and Latinos, Asians and Pacific Islanders, as well as Native Americans and Alaska Natives. Examples might include:
    • Bringing treatment and quality cancer care for people from underserved racial or ethnic groups.
    • Developing an education, outreach, or clinical program purpose built to equalize access to quality cancer care.
    • Finding ways to make cancer care more equitable through innovative economics and technologies.
  • A Nominee should be able to demonstrate measurable impact, whether as people reached, populations served, procedures increased, screens undertaken, partners involved.
  • Ideally, a Nominee’s process/methodology/approach could be applied in other communities to further expand access to similarly underserved populations.

Many of the most promising advances in cancer care come from the area of precision medicine, which uses specific characteristics of a person’s cancer to inform doctors what the best treatment may be for that individual. The Nominee of the C2 Catalyst for Precision Medicine Award is expanding the boundaries for how to personalize care for each person, bringing new, more individualized tests and treatments to patients and improving health outcomes in the process.

A Nominee might have pioneered new research to help oncologists understand the genetics of a person’s cancer differently and thereby provide better treatment options. Or a Nominee may have created new protocols to identify which specific patients may benefit from a specific treatment protocol. This award celebrates those who enhance the ability to provide the right treatment for the right person at the right time.

Award Criteria

  • A Nominee needs to significantly improve personalized treatments for people with cancer, giving them new options. Examples include:
    • Developing a new kind of precision-oncology method that leads to measurable improvements in health outcomes.
    • Developing tools to help identify those who may benefit from a new precision-oncology approach.
    • Leading research that identifies new, more personalized options for cancer treatment.
    • Spearheading a new policy to enhance testing or screening for a specific cancer mutation.
  • A winner should be able to demonstrate measurable impact, such as people treated, programs started, etcetera.
  • Ideally, the tools or techniques required to implement the winner’s activity or program should be something that could apply across the country.

Cancer does not have any fixed rules, nor does the President’s Award, save one: The winner must make a tangible and inspiring difference in the lives of people with cancer or their loved ones. A Nominee may have started a 5K race to raise enough money to pay a certain person’s treatment. A Nominee may have built a cancer survivor support group or online forum. A Nominee might even have changed a loved one’s life by becoming an advocate or caregiver or a volunteer hospice worker. The President’s Award is selected by an AstraZeneca executive for those making a meaningful impact on the lives of people with cancer.

Award Criteria

  • The winner’s contributions benefited the cancer community in an inspirational way that lies outside of the criteria for the other the Cancer Community Awards.
  • This winner should show an unexpected way to contribute to the cancer community and demonstrate how they have improved the life of even one person with cancer.

Our Partner

scientific_american_logo

Our Partner

The program is a partnership between AstraZeneca and Scientific American Custom Media. Scientific American has been bringing its global audience unique insights for more than 170 years.

Nominees will be selected by a broad group of experts drawn from our community, including patient advocates, healthcare providers, leaders in the industry, and members of government agencies.